Rab35 is required for Wnt5a/Dvl2-induced Rac1 activation and cell migration in MCF-7 breast cancer cellsYichao Zhu, Luo Gu, Yujie Zhang et al.|Cellular Signalling|2013Cited by 57
Induction Therapy of Tislelizumab Combined with Cisplatin and 5-Fluorouracil and Subsequent Conversion Surgery in Patients with Unresectable Advanced Esophageal Squamous Cell Carcinoma: A Phase 2, Single Center StudyTongpeng Xu, Yue Zhou, Jian’an Bai et al.|Annals of Surgical Oncology|2024Cited by 8